Amyris Commences Chapter 11 Bankruptcy Process
Amyris, a synthetic biotechnology company, is moving forward with an operational and financial restructuring to further advance its ongoing strategic transformation and position the company for long-term success.
August 10, 2023
Amyris | Ankura Consulting Group | Han Kieftenbeld | Intrepid Investment Bankers | Pachulski Stang Ziehl & Jones | Philip J. Gund | PricewaterhouseCoopers
Ian Koplin